Media Advisory - Dr. Chamberland, Expert Spokesperson available to discuss legalization of recreational cannabis

News provided by

Oct 15, 2018, 07:00 ET

ORLEANS, ON, Oct. 15, 2018 /CNW/ -

Who:	Dr. Guy Chamberland, M.Sc., Ph.D.,

	Interim CEO and Chief Scientific Officer, Tetra Bio-Pharma

Recent live and pre-taped media experience:

Background:

Tetra Bio-Pharma is a global leader in the discovery and development of cannabis and cannabinoid drugs. www.tetrabiopharma.com
Tetra is the only company in North America working with Health Canada and the FDA on clinical trial programs that lead to prescription cannabis drugs.
Dr. Chamberland has 22 + years of experience in drug development expertise in regulatory affairs, and the development and management of clinical research protocols and clinical studies for botanical medicines.
He is fluently bilingual and a recognized expert in botanical medicine, publishing, lecturing and delivering continuing education workshops on the use of plants in the treatment of such areas as pain, anxiety, insomnia, and wound healing.
He is Professor of Botanical Medicine and Principles of clinical research at the Ecole d'Enseignement Superieur de Naturopathie du Quebec (EESNQ).

Topics:

Is there a way to consume recreational cannabis safely?
If you have a health condition and plan to use recreational cannabis – what are the risks?
Should we expect an increase in ER visits after October 17 and why?
Should we worry about the lack of scientific evidence to prove the safety and efficacy of cannabis?
Will doctors, regulators like Health Canada and bodies like the Canadian Medical Association ever approve cannabis use?
How far is Canada/the US away from having cannabis in pharmacies, and covered by insurance?

An excellent speaker, Dr. Chamberland is available for media appearances in the Montreal/Southern Ontario region.

SOURCE Tetra Bio-Pharma

please contact: energi PR, Stephanie Engel, 416-425-9143 ext. 209, [email protected]; Carol Levine, 514-288-8500 ext. 225, [email protected]